References
- Alkhatib NS, Erstad B, Ramos K, et al. Pricing methods in outcome-based contracting-δ1: cost-effectiveness analysis and cost utility analysis-based pricing. J Med Econ. 2020;23(11):1215–1222.
- Alkhatib NS, Ramos K, Erstad B, et al. Pricing methods in outcome-based contracting-δ2: willingness-to-pay-based pricing. J Med Econ. 2020;23(11):1223–1229.
- Alkhatib NS, Erstad B, Ramos K, et al. Pricing methods in outcome-based contracting-δ3: reference-based pricing. J Med Econ. 2020;23(11):1230–1236.
- PhRMA. Value-based contracts: 2009-Q1 2018. USA; 2018 [accessed December 2019]. Available from: http://phrma-docs.phrma.org/files/dmfile/PhRMA_ValueBasedContracts_V9.pdf
- Martin J. Probability given odds. [accessed December 2019]. Available from: https://www.ctspedia.org/do/view/CTSpedia/OddsTerm#Calculating_Probability_Given_Od
- Ho AM, Dion PW, Karmakar MK, et al. Estimating with confidence the risk of rare adverse events, including those with observed rates of zero. Reg Anesth Pain Med. 2002;27:207–210.
- Briggs A, Claxton K, Sculpher M. Decision modelling for health economic evaluation. New York (NY): Oxford University Press; 2011.
- Kenneth RJ. Epidemiology: an introduction. 2nd ed. New York (NY): Oxford University Press; 2012. p. 66–167.
- Soria J, Ohe Y, Vansteenkiste J, et al. Osimertinib in untreated EGFR-mutated advanced non–small-cell lung cancer. N Engl J Med. 2018;378:113–125.
- RedBook Online [subscription database onlie]. Updated periodically. Greenwood Village (CO): Truven Health Analytics. [Accessed December 2019]. Available from: http://micromedex.com/products/product-suites/clinical-knowledge/redbook
- U.S. Bureau of Labor Statistics. Prescription drugs in U.S. city average, all urban consumers, seasonally adjusted. [accessed December 2019]. Available from: https://data.bls.gov/timeseries/CUSR0000SEMF01?output_view=pct_3mths
- Garrison LP, Towse A, Briggs A, et al. Performance-based risk-sharing arrangements-good practices for design, implementation, and evaluation: report of the ISPOR good practices for performance-based risk-sharing arrangements task force. Value Health. 2013;16:703–719.
- Zikmund-Fisher BJ, Fagerlin A, Roberts TR, et al. Alternate methods of framing information about medication side effects: incremental risk versus total risk of occurrence. J Health Commun. 2008;13:107–124.
- Griffith D. Four types of price variation. Laramie (WY); 2013 [accessed December 2019]. Available from: http://www.uwagec.org/rightrisk/presentations/2013_03_26_DGriffithMarketing/1_Introduction/1_FourTypesPriceVariation.pdf